Furthermore, we assessed the expression level of GLUT1 in clinical pancreatic cancer samples, and its positive rate correlated with survival and clinical characteristics, including tumor size, the degree of tumor differentiation, and the status of lymph node metastasis. Here, SLC2A1 is linked to neoplasm.